by Dorte Heide | Aug 17, 2020 | Succes Stories
Neuronicon Technology sold to the pharmaceutical group Lundbeck. Through research, Neuronicon has produced new knowledge that in the long term can lead to new types of medicine that can curb serious brain diseases, for example Alzheimer’s, and disabling brain...
Recent Comments